Jun 08, 2020
Prime Therapeutics and EMD Serono ink value-based agreement on MAVENCLAD® (cladribine) tablets
May 27, 2020
Rebif® U.S. Label Now Includes Pregnancy Outcomes and Lactation Information to Help Inform Treatment Decisions for Women with MS
May 23, 2020
New Late-Breaking Data at EAN Indicate Evobrutinib is the First BTK Inhibitor to Report Efficacy and Safety in MS Over 108 Weeks
Oct 08, 2019
EMD Serono Announces JAMA Publication of Phase II Results of Sprifermin for Osteoarthritis Structure Modification
Sep 10, 2019
EMD Serono Initiates Pivotal Phase III Program for Investigational Evobrutinib in Relapsing Multiple Sclerosis
Aug 28, 2019
EMD Serono to Showcase Scientific Leadership at ECTRIMS 2019 with New Data Across Multiple Sclerosis Medicines
Feb 04, 2019
Elizabeth Varki Jobes, Esq. Joins EMD Serono as Chief Compliance Officer North America
Oct 02, 2018
Accelerated Cure Project Announces Collaboration with EMD Serono to Advance Patient-Focused Drug Development in Multiple Sclerosis
Aug 31, 2018
Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America
May 29, 2018
EMD Serono to Present MS Data and Debut New Patient Resources at CMSC 2018
Apr 30, 2018
14th Annual EMD Serono Specialty Digest(TM) Educates Health Plans on Latest Trends in Unmet Payer Needs and Patient-Centric Services
Apr 23, 2018
EMD Serono R&D Building Earns First WELL Gold Certification(TM) in U.S. for New & Existing Building Project
Apr 13, 2018
EMD Serono Highlights Commitment to Advance Multiple Sclerosis Treatment with Investigational Cladribine Tablets and Rebif® Data at AAN 2018
Mar 22, 2018
EMD Serono to Collaborate with March of Dimes to Improve Health of Mothers and Babies
Mar 06, 2018
Wendy Sussman Joins EMD Serono as Vice President of U.S. Healthcare Government & Public Affairs
Feb 01, 2018
EMD Serono to Present Data Highlighting Investigational Cladribine Tablets at ACTRIMS 2018
Dec 07, 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
Dec 05, 2017
EMD Serono Announces FDA 510(k) Clearance of Partner Genea Biomedx's Fertility Benchtop Incubator Geri(TM)
Dec 01, 2017
EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
Nov 13, 2017
EMD Serono Receives FDA Approval for New GONAL-f® RFF Redi-ject® Pen